盘前必读丨美国准备23日与伊朗对话；高端医疗器械新政将出台

Group 1 - The overall A-share market is expected to show a fluctuating upward trend in the second half of 2025, but attention should be paid to overseas uncertainties and the pace of domestic economic recovery [1][18] - The Shanghai Stock Exchange has officially implemented guidelines for designated trading business [2] - The Nasdaq China Golden Dragon Index fell by 0.9%, with major Chinese stocks like JD.com and Baidu experiencing declines [6] Group 2 - The U.S. stock market closed mixed, with the Dow Jones Industrial Average up by 0.08% and the Nasdaq down by 0.51% [4] - Major tech stocks showed divergence, with Google down 3.6% due to European antitrust investigations, while Apple rose by 2.2% [5] - The Philadelphia Fed's manufacturing index for June reported -4.0, indicating continued contraction in the manufacturing sector [7] Group 3 - International oil prices weakened, with WTI crude oil down 0.28% to $74.93 per barrel, and Brent crude down 2.23% to $77.01 per barrel [8] - International gold prices faced downward pressure, with COMEX gold futures for June delivery down 0.64% to $3368.10 per ounce [9] Group 4 - The China Securities Regulatory Commission is conducting a national quality supervision inspection of 164 products, with a total of over 16,000 batches to be sampled [10] - The National Medical Products Administration is implementing measures to support the innovation of high-end medical devices [11] - Ping An Life has increased its stake in China Merchants Bank H-shares for the third time, reaching 15% of the bank's H-share capital [17]